Pfizer Inc.

NYSE:PFE   3:59:59 PM EDT
44.10
-0.47 (-1.06%)
4:08:38 PM EDT: $44.07 -0.03 (-0.07%)
Products

FDA Authorizes Moderna, Pfizer-Biontech Bivalent Covid-19 Vaccines For Use As A Booster Dose

Published: 08/31/2022 13:56 GMT
Pfizer Inc. (PFE) - FDA Authorizes Moderna, Pfizer-biontech Bivalent Covid-19vaccines for Use As a Booster Dose.
FDA - Moderna Covid-19 Vaccine, Bivalent, is Authorized for Use As a Single Booster Dose in Individuals 18 Years of Age and Older.
FDA Says Pfizer-biontech Covid-19 Vaccine, Bivalent, is Authorized for Use As a Single Booster Dose in Individuals 12 Years of Age and Older.
FDA - Pfizer-biontech Covid-19 Vaccine, Bivalent, is Authorized for Use As a Single Booster Dose in Individuals 12 Years of Age and Older.
FDA - With Aug 31 St Authorization, Monovalent Mrna Covid-19 Vaccines Are Not Authorized As Booster Doses for Individuals 12 Years of Age and Older.
FDA - Revised Eua of Moderna Covid-19 Vaccine, Pfizer-biontech Covid-19 Vaccine to Remove Use of Monovalent Moderna for Booster Administration for 18 Years and Older.
FDA - Revised Eua of Pfizer-biontech Covid-19 Vaccine to Remove Use of Pfizer-biontech Covid-19 Vaccines for Booster Administration for 12 Years and Older.
Further Company Coverage: Pfen ((reuters.
Briefs@thomsonreuters.
Com;)).